Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion.
about
National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008.Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell diseaseSickle red cell-endothelium interactions.Participation of Mac-1, LFA-1 and VLA-4 integrins in the in vitro adhesion of sickle cell disease neutrophils to endothelial layers, and reversal of adhesion by simvastatinNewer aspects of the pathophysiology of sickle cell disease vaso-occlusion.Single-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain crisis.Microfluidic study of enhanced deposition of sickle cells at acute corners.Inflammatory targets of therapy in sickle cell disease.Sickle cell vaso-occlusive crisis: it's a gut feeling.Factors associated with survival in a contemporary adult sickle cell disease cohort.The paradox of the neutrophil's role in tissue injury.Emerging point-of-care technologies for sickle cell disease screening and monitoring.Inhibition of phosphodiesterase 9A reduces cytokine-stimulated in vitro adhesion of neutrophils from sickle cell anemia individuals.Prominent role of platelets in the formation of circulating neutrophil-red cell heterocellular aggregates in sickle cell anemia.Treating sickle cell anaemia with hydroxycarbamide.Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion.Fibronectin bridges monocytes and reticulocytes via integrin alpha4beta1.VLA-4 blockade by natalizumab inhibits sickle reticulocyte and leucocyte adhesion during simulated blood flow.
P2860
Q34253814-DEC3EA58-835C-4240-8C84-7CF67C4568AAQ34255075-89BC5C8E-CB8B-4A8C-9B42-B6212A146D2FQ34686539-0D30FB09-DA26-4071-BB2C-C4BE2D219D3AQ34750520-881D843C-27B4-43B3-AA2E-9CAFF90320F6Q34941213-ECB95E0B-6090-4599-9BFB-9F49EE42092EQ35537053-E199DAAD-CBD8-46BD-A277-296CD0F5EE17Q35688344-EF570E47-9FD2-431F-9E8A-F00A8E7A319AQ36385224-62875D36-7751-4389-9C63-158B20C06F74Q37466462-08002E26-E015-4269-BD09-8EC036466B63Q37705175-5FC0DA67-2CE4-434E-B13B-3742E95D8A27Q37811628-5BB6B380-C069-483C-A830-2C8F9A82EB9EQ38804432-2918FD89-0264-43B3-B807-EC5AAE3DBCDEQ42484224-0480C9CC-1EB9-4304-A334-6DD475ACC84EQ42979946-9AB725A4-34C8-4EA5-B223-FD59F15A44F7Q44076004-7F3E31C7-C74F-41DF-BAAF-1F42C4E926AEQ50230368-20D23E94-A0FC-420E-BF05-79739B033584Q50652273-3DB82C6A-9F81-4947-BD6A-B81CAADE974AQ51707094-2E1851B7-5CE0-4527-AADD-BCB6EA6C3ED8
P2860
Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Adherent leukocytes capture si ...... flow model of vaso-occlusion.
@en
Adherent leukocytes capture si ...... flow model of vaso-occlusion.
@nl
type
label
Adherent leukocytes capture si ...... flow model of vaso-occlusion.
@en
Adherent leukocytes capture si ...... flow model of vaso-occlusion.
@nl
prefLabel
Adherent leukocytes capture si ...... flow model of vaso-occlusion.
@en
Adherent leukocytes capture si ...... flow model of vaso-occlusion.
@nl
P2093
P356
P1476
Adherent leukocytes capture si ...... flow model of vaso-occlusion.
@en
P2093
Aslihan Turhan
David E Golan
Eileen M Finnegan
P304
P356
10.1002/AJH.20819
P577
2007-04-01T00:00:00Z